NARITA Tomoko

Researcher Information

J-Global ID

• 201701007973797501

Research Areas

• Other / Other

Published Papers

• Impact of MYD88 and/or CD79B mutations on central nervous system relapse in patients with diffuse large B-cell lymphoma.

  Tomotaka Suzuki; Keiichiro Fujii; Naohiro Matsunaga; Hirokazu Sasaki; Takashi Kanamori; Arisa Asano; Shiori Kinoshita; Tomoko Narita; Ayako Masaki; Takaomi Sanda; Masaki Ri; Shigeru Kusumoto; Hirokazu Komatsu; Shinsuke Iida; Hiroshi Inagaki

  British journal of haematology 2025/04
• Clinical Significance of Cytomegalovirus Reactivation in Patients With Plasma Cell Dyscrasia Who Were Treated With Anti-CD38 Monoclonal Antibody: A Retrospective Analysis in a Single Institution.

  Naohiro Matsunaga; Tomotaka Suzuki; Nozomi Nishitarumizu; Yoko Nakanishi; Aki Kondo; Yukiyasu Kato; Toru Ebina; Yoshiaki Marumo; Tomoyuki Nakamura; Takahiro Nakashima; Shiori Kinoshita; Tomoko Narita; Masaki Ri; Shigeru Kusumoto; Hirokazu Komatsu; Shinsuke Iida

  Clinical lymphoma, myeloma & leukemia 24 (8) 531 - 536 2024/08
• Comprehensive analysis of serum cytokines in patients with multiple myeloma before and after lenalidomide and dexamethasone

  Takuto Tachita; Masaki Ri; Sho Aoki; Arisa Asano; Takashi Kanamori; Haruhito Totani; Shiori Kinoshita; Yu Asao; Tomoko Narita; Ayako Masaki; Asahi Ito; Shigeru Kusumoto; Hirokazu Komatsu; Shinsuke Iida

  Cancer Medicine 2024/07 [Refereed]
  
• Fulminant hepatitis in a hepatitis B surface antigen‐positive patient with adult T‐cell leukemia‐lymphoma after mogamulizumab monotherapy

  Takahiro Nakashima; Shigeru Kusumoto; Takashi Ishida; Chie Kato; Shinya Hagiwara; Tomoko Narita; Ayako Masaki; Asahi Ito; Masaki Ri; Hirokazu Komatsu; Hiroshi Inagaki; Yasuhito Tanaka; Shinsuke Iida

  Hepatology Research Wiley 1386-6346 2024/05
• 骨髄腫治療における、有害事象によるカルフィルゾミブ早期中止

  海老名 徹; 鈴木 智貴; 西垂水 希美; 近藤 明希; 中西 陽子; 加藤 佑希康; 松永 尚大; 丸茂 義晃; 浅野 有彩; 木下 史緒理; 成田 朋子; 李 政樹; 楠本 茂; 小松 弘和; 飯田 真介

  日本血液学会学術集会 (一社)日本血液学会 85回 642 - 642 2023/10
• 悪性リンパ腫に合併した自己免疫性溶血性貧血の13例についての検討

  西垂水 希美; 鈴木 智貴; 近藤 明希; 中西 陽子; 加藤 佑希康; 松永 尚大; 海老名 徹; 丸茂 義晃; 浅野 有彩; 木下 史緒理; 成田 朋子; 正木 彩子; 李 正樹; 楠本 茂; 小松 弘和; 稲垣 宏; 飯田 真介

  日本血液学会学術集会 (一社)日本血液学会 85回 1210 - 1210 2023/10
• 初診時に末梢血の形質細胞比率が5-19%であった多発性骨髄腫患者の生存期間および臨床的特徴の解析

  中西 陽子; 鈴木 智貴; 橋本 大哉; 西垂水 希美; 近藤 明希; 加藤 佑希康; 松永 尚大; 海老名 徹; 丸茂 義晃; 浅野 有彩; 木下 史緒理; 成田 朋子; 李 政樹; 楠本 茂; 小松 弘和; 飯田 真介

  日本血液学会学術集会 (一社)日本血液学会 85回 1355 - 1355 2023/10
• Simplified frailty scaleにおけるfrail患者のさらなる層別化

  加藤 佑希康; 鈴木 智貴; 橋本 大哉; 西垂水 希美; 近藤 明希; 中西 陽子; 松永 尚大; 海老名 徹; 丸茂 義晃; 浅野 有彩; 木下 史緒理; 成田 朋子; 李 政樹; 楠本 茂; 小松 弘和; 飯田 真介

  日本血液学会学術集会 (一社)日本血液学会 85回 1533 - 1533 2023/10
• Humoral and cellular immune response to second and third severe acute respiratory syndrome coronavirus 2 mRNA vaccine in patients with plasma cell dyscrasia.

  Tomotaka Suzuki; Shigeru Kusumoto; Yoshiko Kamezaki; Hiroya Hashimoto; Nozomi Nishitarumizu; Yoko Nakanishi; Yukiyasu Kato; Akimi Kawai; Naohiro Matsunaga; Toru Ebina; Tomoyuki Nakamura; Yoshiaki Marumo; Kana Oiwa; Shiori Kinoshita; Tomoko Narita; Asahi Ito; Atsushi Inagaki; Masaki Ri; Hirokazu Komatsu; Takashi Aritsu; Shinsuke Iida

  Cancer medicine 2023/04
• A comprehensive evaluation of humoral immune response to second and third SARS-CoV-2 mRNA vaccination in patients with malignant lymphoma.

  Tomotaka Suzuki; Shigeru Kusumoto; Yoshiko Kamezaki; Hiroya Hashimoto; Nozomi Nishitarumizu; Yoko Nakanishi; Yukiyasu Kato; Akimi Kawai; Naohiro Matsunaga; Toru Ebina; Tomoyuki Nakamura; Yoshiaki Marumo; Kana Oiwa; Shiori Kinoshita; Tomoko Narita; Asahi Ito; Atsushi Inagaki; Masaki Ri; Hirokazu Komatsu; Takashi Aritsu; Shinsuke Iida

  International journal of hematology 1 - 10 2023/02
• Recurrent pain attacks during romiplostim treatment in a patient with ITP carrying a heterozygous MEFV mutation.

  Shiori Kinoshita; Hirokazu Komatsu; Haruna Fujinami; Takashi Yoshida; Tomotaka Suzuki; Tomoko Narita; Asahi Ito; Masaki Ri; Shigeru Kusumoto; Shinsuke Iida

  International journal of hematology 117 (2) 283 - 286 2023/02
• Case report: Genomic analysis of a therapy-related chronic myelomonocytic leukemia with KMT2A rearrangement that progressed to acute myeloid leukemia with acute promyelocytic leukemia-like features.

  Tomotaka Suzuki; Rui Yokomori; Takaomi Sanda; Takaki Kikuchi; Yoshiaki Marumo; Shiori Kinoshita; Tomoko Narita; Ayako Masaki; Asahi Ito; Masaki Ri; Shigeru Kusumoto; Hirokazu Komatsu; Hiroshi Inagaki; Shinsuke Iida

  Frontiers in oncology 13 1116418 - 1116418 2023
• Aberrant tryptophan metabolism leads to unfavorable outcomes in lenalidomide‐treated myeloma patients

  Arisa Asano; Masaki Ri; Ayako Masaki; Yasuhiro Maeda; Takuto Tachita; Kentaro Hirade; Yoshiaki Marumo; Takahiro Nakashima; Shinya Hagiwara; Shiori Kinoshita; Tomotaka Suzuki; Tomoko Narita; Shigeru Kusumoto; Hirokazu Komatsu; Hiroshi Inagaki; Shinsuke Iida

  Hematological Oncology Wiley 0278-0232 2022/12
• Management of hepatitis B virus (HBV) reactivation in patients with resolved HBV infection based on a highly sensitive HB core-related antigen assay.

  Shinya Hagiwara; Shigeru Kusumoto; Takako Inoue; Shintaro Ogawa; Tomoko Narita; Asahi Ito; Masaki Ri; Hirokazu Komatsu; Takanori Suzuki; Kentaro Matsuura; Shintaro Yagi; Atsushi Kaneko; Katsumi Aoyagi; Shinsuke Iida; Yasuhito Tanaka

  Hepatology research : the official journal of the Japan Society of Hepatology 2022/02
• Propensity-score matched analysis of the efficacy of maintenance/continuous therapy in newly diagnosed patients with multiple myeloma: a multicenter retrospective collaborative study of the Japanese Society of Myeloma.

  Shuji Ozaki; Hiroshi Handa; Hiromi Koiso; Takayuki Saitoh; Kazutaka Sunami; Tadao Ishida; Kenshi Suzuki; Tomoko Narita; Shinsuke Iida; Yuichi Nakamura; Kazuhito Suzuki; Noriko Nishimura; Hirokazu Murakami; Kazuyuki Shimizu

  Journal of cancer research and clinical oncology 2021/06
• 多発性骨髄腫の継続・維持療法の有効性に関する傾向スコアマッチング解析(Propensity-score matched analysis of the efficacy of maintenance or continuous therapy on multiple myeloma)

  尾崎 修治; 半田 寛; 小磯 博美; 齋藤 貴之; 角南 一貴; 石田 禎夫; 鈴木 憲史; 成田 朋子; 飯田 真介; 中村 裕一; 鈴木 一史; 西村 倫子; 村上 博和; 清水 一之

  International Journal of Myeloma (一社)日本骨髄腫学会 11 (2) 96 - 96 2021/05
• Genomic analysis of multiple myeloma using targeted capture sequencing in the Japanese cohort.

  Takashi Kanamori; Masashi Sanada; Masaki Ri; Hiroo Ueno; Dai Nishijima; Takahiko Yasuda; Takuto Tachita; Tomoko Narita; Shigeru Kusumoto; Atsushi Inagaki; Rei Ishihara; Yuki Murakami; Nobuhiko Kobayashi; Yusuke Shiozawa; Kenichi Yoshida; Masahiro M Nakagawa; Yasuhito Nannya; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Satoru Miyano; Keizo Horibe; Hiroshi Handa; Seishi Ogawa; Shinsuke Iida

  British journal of haematology 191 (5) 755 - 763 2020/12
• Clinical significance of tryptophan catabolism in follicular lymphoma.

  Ayako Masaki; Takashi Ishida; Yasuhiro Maeda; Asahi Ito; Susumu Suzuki; Tomoko Narita; Shiori Kinoshita; Takashi Yoshida; Masaki Ri; Shigeru Kusumoto; Hirokazu Komatsu; Hiroshi Inagaki; Ryuzo Ueda; Ilseung Choi; Youko Suehiro; Shinsuke Iida

  Hematological oncology 38 (5) 742 - 753 2020/12
• Clinical features of anthracycline-induced cardiotoxicity in patients with malignant lymphoma who received a CHOP regimen with or without rituximab: A single-center, retrospective observational study.

  Takafumi Nakayama; Yoshiko Oshima; Shigeru Kusumoto; Junki Yamamoto; Satoshi Osaga; Haruna Fujinami; Takaki Kikuchi; Tomotaka Suzuki; Haruhito Totani; Shiori Kinoshita; Tomoko Narita; Asahi Ito; Masaki Ri; Hirokazu Komatsu; Kazuaki Wakami; Toshihiko Goto; Tomonori Sugiura; Yoshihiro Seo; Nobuyuki Ohte; Shinsuke Iida

  EJHaem 1 (2) 498 - 506 2020/11
• Hepatitis B virus reactivation in a myeloma patient with resolved infection who received daratumumab-containing salvage chemotherapy.

  Takaki Kikuchi; Shigeru Kusumoto; Yasuhito Tanaka; Yoshiko Oshima; Haruna Fujinami; Tomotaka Suzuki; Haruhito Totani; Shiori Kinoshita; Yu Asao; Tomoko Narita; Asahi Ito; Masaki Ri; Hirokazu Komatsu; Shinsuke Iida

  Journal of clinical and experimental hematopathology : JCEH 60 (2) 51 - 54 2020/06
• Immunohistochemistry for identification of CCND1, NSD2, and MAF gene rearrangements in plasma cell myeloma.

  Murase T; Ri M; Narita T; Fujii K; Masaki A; Iida S; Inagaki H

  Cancer science 110 (8) 2600 - 2606 1347-9032 2019/08 [Refereed]
  
• Plasma cell myeloma positive for t(14;20) with relapse in the central nervous system.

  Murase T; Inagaki A; Masaki A; Fujii K; Narita T; Ri M; Hanamura I; Iida S; Inagaki H

  Journal of clinical and experimental hematopathology : JCEH 1346-4280 2019/08 [Refereed]
  
• Exophiala dermatitidis Fungemia Diagnosed Using Time-of-flight Mass Spectrometry during Chemotherapy for Malignant Lymphoma and Successful Treatment with Voriconazole.

  Takashi Yoshida; Takuto Tachita; Haruna Fujinami; Yoshiko Oshima; Hirokazu Sasaki; Yoshiaki Marumo; Tomoko Narita; Asahi Ito; Masaki Ri; Shigeru Kusumoto; Takashi Ishida; Hirokazu Komatsu; Shinsuke Iida

  Internal medicine (Tokyo, Japan) 58 (15) 2219 - 2224 2019/08 [Refereed]
  
• Impact of chromosomal abnormalities on the efficacy of lenalidomide plus dexamethasone treatment in patients with relapsed/refractory multiple myeloma.

  Takashi Yoshida; Masaki Ri; Haruna Fujinami; Yoshiko Oshima; Takuto Tachita; Yoshiaki Marumo; Hirokazu Sasaki; Shiori Kinoshita; Haruhito Totani; Tomoko Narita; Ayako Masaki; Asahi Ito; Shigeru Kusumoto; Takashi Ishida; Hirokazu Komatsu; Shinsuke Iida

  International journal of hematology 110 (2) 228 - 236 2019/08 [Refereed]
  
• Pre- and post-transplant ponatinib for a patient with acute megakaryoblastic blast phase chronic myeloid leukemia with T315I mutation who underwent allogeneic hematopoietic stem cell transplantation.

  Hirokazu Sasaki; Sachiko Mitani; Shigeru Kusumoto; Yoshiaki Marumo; Arisa Asano; Takashi Yoshida; Tomoko Narita; Asahi Ito; Hiroki Yano; Masaki Ri; Takashi Ishida; Hirokazu Komatsu; Shinsuke Iida

  International journal of hematology 110 (1) 119 - 123 2019/07 [Refereed]
  
• Expression analysis of two SLAM family receptors, SLAMF2 and SLAMF7, in patients with multiple myeloma.

  Reham Ashour; Masaki Ri; Sanaa Shaker Aly; Takashi Yoshida; Takuto Tachita; Takashi Kanamori; Sho Aoki; Shiori Kinoshita; Tomoko Narita; Haruhito Totani; Ayako Masaki; Asahi Ito; Shigeru Kusumoto; Hirokazu Komatsu; Samar Mansour; Abdelrahman A Elsaied; Shinsuke Iida

  International journal of hematology 110 (1) 69 - 76 2019/07 [Refereed]
  
• Clinical Implications of t(11;14) in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation.

  Hiroyuki Takamatsu; Takeshi Yamashita; Shingo Kurahashi; Takayuki Saitoh; Tadakazu Kondo; Takeshi Maeda; Hideyuki Nakazawa; Makoto Murata; Tomoko Narita; Junya Kuroda; Hisako Hashimoto; Koji Kawamura; Toshihiro Miyamoto; Sumihisa Honda; Tatsuo Ichinohe; Yoshiko Atsuta; Kazutaka Sunami

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 25 (3) 474 - 479 1083-8791 2019/03 [Refereed]
  
• [Richter syndrome successfully treated with ibrutinib monotherapy: two case reports].

  Haruna Fujinami; Shigeru Kusumoto; Ayako Masaki; Yoshiko Ohshima; Takuto Tachita; Hirokazu Sasaki; Yoshiaki Marumo; Takashi Yoshida; Tomoko Narita; Asahi Ito; Masaki Ri; Hirokazu Komatsu; Hiroshi Inagaki; Shinsuke Iida

  [Rinsho ketsueki] The Japanese journal of clinical hematology 60 (10) 1462 - 1467 2019 [Refereed]
  
• Human T-cell lymphotropic/leukemia virus type 1 (HTLV-1) Tax-specific T-cell exhaustion in HTLV-1-infected individuals.

  Masaki A; Ishida T; Suzuki S; Ito A; Narita T; Kinoshita S; Ri M; Kusumoto S; Komatsu H; Inagaki H; Ueda R; Iida S

  Cancer science 109 (8) 2383 - 2390 1347-9032 2018/08 [Refereed]
  
• Cyclin-dependent kinase 9 as a potential specific molecular target in NK cell leukemia/lymphoma.

  Kinoshita S; Ishida T; Ito A; Narita T; Masaki A; Suzuki S; Yoshida T; Ri M; Kusumoto S; Komatsu H; Shimizu N; Inagaki H; Kuroda T; Scholz A; Ueda R; Sanda T; Iida S

  Haematologica 103 (12) 2059 - 2068 0390-6078 2018/08 [Refereed]
  
• Clinical evaluation of a novel and highly sensitive immunoassay for anti-hepatitis B core antigen using a fully automated immunochemical analyzer.

  Izumida K; Kaneko A; Takahashi K; Kusumoto S; Narita T; Takami A; Iida S; Aoyagi K; Tanaka Y

  Hepatology research : the official journal of the Japan Society of Hepatology 48 (13) 1081 - 1091 1386-6346 2018/07 [Refereed]
  
• Potent antitumor effect of combination therapy with sub-optimal doses of akt inhibitors and pomalidomide plus dexamethasone in multiple myeloma

  Shiori Kinoshita; Masaki Ri; Takashi Kanamori; Sho Aoki; Takashi Yoshida; Tomoko Narita; Haruhito Totani; Asahi Ito; Shigeru Kusumoto; Takashi Ishida; Hirokazu Komatsu; Shinsuke Iida

  Oncology Letters Spandidos Publications 15 (6) 9450 - 9456 1792-1082 2018/06 [Refereed]
  
• Low expression of neural cell adhesion molecule, CD56, is associated with low efficacy of bortezomib plus dexamethasone therapy in multiple myeloma

  Takashi Yoshida; Masaki Ri; Shiori Kinoshita; Tomoko Narita; Haruhito Totani; Reham Ashour; Asahi Ito; Shigeru Kusumoto; Takashi Ishida; Hirokazu Komatsu; Shinsuke Iida

  PLoS ONE Public Library of Science 13 (5) e0196780  1932-6203 2018/05 [Refereed]
  
• Clinical significance of tryptophan catabolism in Hodgkin lymphoma

  Ayako Masaki; Takashi Ishida; Yasuhiro Maeda; Asahi Ito; Susumu Suzuki; Tomoko Narita; Shiori Kinoshita; Hisashi Takino; Takashi Yoshida; Masaki Ri; Shigeru Kusumoto; Hirokazu Komatsu; Hiroshi Inagaki; Ryuzo Ueda; Ilseung Choi; Youko Suehiro; Shinsuke Iida

  Cancer Science Blackwell Publishing Ltd 109 (1) 74 - 83 1349-7006 2018/01 [Refereed]
  
• [Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance mimicking POEMS syndrome].

  Kanamori T; Kusumoto S; Okita K; Hagiwara S; Kato C; Nakashima T; Murakami S; Narita T; Ito A; Ri M; Ishida T; Komatsu H; Matsukawa N; Iida S

  [Rinsho ketsueki] The Japanese journal of clinical hematology 59 (2) 161 - 166 0485-1439 2018 [Refereed]
  
• Potent anti-tumor activity of a syringolin analog in multiple myeloma: A dual inhibitor of proteasome activity targeting β2 and β5 subunits

  Takashi Yoshida; Masaki Ri; Takashi Kanamori; Sho Aoki; Reham Ashour; Shiori Kinoshita; Tomoko Narita; Haruhito Totani; Ayako Masaki; Asahi Ito; Shigeru Kusumoto; Takashi Ishida; Hirokazu Komatsu; Shun Kitahata; Takuya Chiba; Satoshi Ichikawa; Shinsuke Iida

  Oncotarget Impact Journals LLC 9 (11) 9975 - 9991 1949-2553 2018 [Refereed]
  
• [Thrombosis in multiple myeloma].

  Narita T

  [Rinsho ketsueki] The Japanese journal of clinical hematology 59 (8) 1027 - 1033 0485-1439 2018 [Refereed]
  
• Epigenetic repression of miR-375 is the dominant mechanism for constitutive activation of the PDPK1/RPS6KA3 signalling axis in multiple myeloma

  Shotaro Tatekawa; Yoshiaki Chinen; Masaki Ri; Tomoko Narita; Yuji Shimura; Yayoi Matsumura-Kimoto; Taku Tsukamoto; Tsutomu Kobayashi; Eri Kawata; Nobuhiko Uoshima; Tomohiko Taki; Masafumi Taniwaki; Hiroshi Handa; Shinsuke Iida; Junya Kuroda

  BRITISH JOURNAL OF HAEMATOLOGY 178 (4) 534 - 546 0007-1048 2017/08 [Refereed]
  
• Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphoma

  Tomoko Narita; Takashi Ishida; Asahi Ito; Ayako Masaki; Shiori Kinoshita; Susumu Suzuki; Hisashi Takino; Takashi Yoshida; Masaki Ri; Shigeru Kusumoto; Hirokazu Komatsu; Kazunori Imada; Yuetsu Tanaka; Akifumi Takaori-Kondo; Hiroshi Inagaki; Arne Scholz; Philip Lienau; Taruho Kuroda; Ryuzo Ueda; Shinsuke Iida

  BLOOD 130 (9) 1114 - 1124 0006-4971 2017/08 [Refereed]
  
• POEMS症候群との鑑別に苦慮したM蛋白を伴う成人発症型ネマリンミオパチーの1例

  金森 貴之; 楠本 茂; 萩原 真也; 加藤 千絵; 中島 貴裕; 村上 五月; 成田 朋子; 伊藤 旭; 李 政樹; 石田 高司; 小松 弘和; 飯田 真介; 大喜多 賢治; 松川 則之

  臨床血液 (一社)日本血液学会-東京事務局 58 (6) 684 - 685 0485-1439 2017/06
• Anti-Myeloma Activity of a Syringolin Analog: A Dual 20S Proteasome Inhibitor of Beta 2 and 5 Subunits

  Takashi Yoshida; Masaki Ri; Shiori Kinoshita; Tomoko Narita; Haruhito Totani; Reham Ashour; Ayako Masaki; Asahi Ito; Shigeru Kusumoto; Takashi Ishida; Hirokazu Komatsu; Satoshi Ichikawa; Shinsuke Iida

  BLOOD 128 (22) 0006-4971 2016/12 [Refereed]
  
• EBV関連T細胞およびNK細胞リンパ増殖性疾患の治療標的としてのCDK9(CDK9 as a target for treatment in EBV-associated T- and NK-cell lymphoproliferative diseases)

  Kinoshita Shiori; Ishida Takashi; Narita Tomoko; Ito Asahi; Masaki Ayako; Suzuki Susumu; Takino Hisashi; Yoshida Takashi; Ri Masaki; Kusumoto Shigeru; Komatsu Hirokazu; Shimizu Norio; Inagaki Hiroshi; Scholz Arne; Ince Stuart; Ueda Ryuzo; Iida Shinsuke

  臨床血液 (一社)日本血液学会-東京事務局 57 (9) 1541 - 1541 0485-1439 2016/09 [Refereed]
  
• Phase I study of once weekly treatment with bortezomib in combination with lenalidomide and dexamethasone for relapsed or refractory multiple myeloma

  Haruhito Totani; Masaki Ri; Chie Kato; Takahiro Nakashima; Nana Suzuki; Shinya Hagiwara; Takashi Kanamori; Satsuki Murakami; Arisa Masuda; Shiori Kinoshita; Takashi Yoshida; Tomoko Narita; Asahi Ito; Shigeru Kusumoto; Takashi Ishida; Hirokazu Komatsu; Shinsuke Iida

  INTERNATIONAL JOURNAL OF HEMATOLOGY 103 (3) 316 - 321 0925-5710 2016/03 [Refereed]
  
• Lower expression of activating transcription factors 3 and 4 correlates with shorter progression-free survival in multiple myeloma patients receiving bortezomib plus dexamethasone therapy.

  Narita T; Ri M; Masaki A; Mori F; Ito A; Kusumoto S; Ishida T; Komatsu H; Iida S

  Blood Cancer J. 2015 Dec 4;5:e373. 2015/12 [Refereed]
  
• Overexpression of salivary-type amylase reduces the sensitivity to bortezomib in multiple myeloma cells

  Shohei Mizuno; Ichiro Hanamura; Akinobu Ota; Sivasundaram Karnan; Tomoko Narita; Masaki Ri; Motonori Mizutani; Mineaki Goto; Mayuko Gotou; Norikazu Tsunekawa; Masato Shikami; Shinsuke Iida; Yoshitaka Hosokawa; Hiroshi Miwa; Ryuzo Ueda; Masakazu Nitta; Akiyoshi Takami

  INTERNATIONAL JOURNAL OF HEMATOLOGY 102 (5) 569 - 578 0925-5710 2015/11 [Refereed]
  
• [Prognostic significance of tryptophan catabolism in adult T-cell leukemia/lymphoma].

  Ayako Masaki; Takashi Ishida; Yasuhiro Maeda; Susumu Suzuki; Asahi Ito; Hisashi Takino; Haruhito Totani; Takashi Yoshida; Shiori Kinoshita; Hiroka Ogura; Tomoko Narita; Masaki Ri; Shigeru Kusumoto; Atsushi Inagaki; Hirokazu Komatsu; Akio Niimi; Ryuzo Ueda; Atae Utsunomiya; Hiroshi Inagaki; Shinsuke Iida

  [Rinsho ketsueki] The Japanese journal of clinical hematology 56 (11) 2295 - 304 0485-1439 2015/11 [Refereed]
  
• Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/Lymphoma

  Ayako Masaki; Takashi Ishida; Yasuhiro Maeda; Susumu Suzuki; Asahi Ito; Hisashi Takino; Hiroka Ogura; Haruhito Totani; Takashi Yoshida; Shiori Kinoshita; Tomoko Narita; Masaki Ri; Shigeru Kusumoto; Atsushi Inagaki; Hirokazu Komatsu; Akio Niimi; Ryuzo Ueda; Atae Utsunomiya; Hiroshi Inagaki; Shinsuke Iida

  CLINICAL CANCER RESEARCH 21 (12) 2830 - 2839 1078-0432 2015/06 [Refereed]
  
• Transplant-related mortality following allogeneic hematopoietic stem cell transplantation using fludarabine/busulfan-based reduced-intensity conditioning - A retrospective analysis in a single institution

  Takashi Yoshida; Shigeru Kusumoto; Arisa Masuda; Haruhito Totani; Tomoko Narita; Ayako Masaki; Asahi Ito; Masaki Ri; Takashi Ishida; Hirokazu Komatsu; Shinsuke Iida

  Japanese Journal of Cancer and Chemotherapy Japanese Journal of Cancer and Chemotherapy Publishers Inc. 42 (6) 719 - 724 0385-0684 2015/06 [Refereed]
  
• t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs.

  Narita T; Inagaki A; Kobayashi T; Kuroda Y; Fukushima T; Nezu M; Fuchida S; Sakai H; Sekiguchi N; Sugiura I; Maeda Y; Takamatsu H; Tsukamoto N; Maruyama D; Kubota Y; Kojima M; Sunami K; Ono T; Ri M; Tobinai K; Iida S

  Blood cancer journal 5 e285  2015/02 [Refereed]
  
• OVEREXPRESSION OF SALIVARY-TYPE AMYLASE REDUCES THE SENSITIVITY TO BORTEZOMIB IN MULTIPLE MYELOMA CELLS

  Mizuno S; Hanamura I; Ota A; Karnan S; Narita T; Ri M; Goto M; Gotou M; Tsunekawa N; Shikami M; Iida S; Hosokawa Y; Miwa H; Ueda R; Masakazu N; Takami A

  HAEMATOLOGICA 100 (1) 249 - 250 2015 [Refereed]
  
• Amylase-Producing Myeloma Cells Reduced Sensitivity to Dexamethasone and Bortezomib.

  Mizuno Shohei; Hanamura Ichiro; Ota Akinobu; Sivasundaram Karnan; Narita Tomoko; Ri Masaki; Mizutani Motonori; Goto Mineaki; Gotou Mayuko; Tsunekawa Norikazu; Shikami Masato; Iida Shinsuke; Hosokawa Yoshitaka; Miwa Hiroshi; Ueda Ryuzo; Nitta Masakazu; Takami Akiyoshi

  BLOOD 124 (21) 0006-4971 2014/12 [Refereed]
  
• Amylaseを形質移入した骨髄腫細胞株の確立とその特徴(Establishment and characterization of myeloma cell lines transfected with amylase)

  Mizuno Shohei; Hanamura Ichiro; Ota Akinobu; Sivasundaram Karnan; Narita Tomoko; Ri Masaki; Goto Mineaki; Gotou Mayuko; Tsunekawa Norikazu; Shikami Masato; Iida Shinsuke; Hosokawa Yoshitaka; Miwa Hiroshi; Ueda Ryuzou; Nitta Masakazu; Takami Akiyoshi

  臨床血液 (一社)日本血液学会-東京事務局 55 (9) 1306 - 1306 0485-1439 2014/09
• Antitumor effects of bevacizumab in a microenvironment-dependent human adult T-cell leukemia/lymphoma mouse model

  Fumiko Mori; Takashi Ishida; Asahi Ito; Fumihiko Sato; Ayako Masaki; Tomoko Narita; Susumu Suzuki; Tomiko Yamada; Hisashi Takino; Masaki Ri; Shigeru Kusumoto; Hirokazu Komatsu; Masakatsu Hishizawa; Kazunori Imada; Akifumi Takaori-Kondo; Akio Niimi; Ryuzo Ueda; Hiroshi Inagaki; Shinsuke Iida

  EUROPEAN JOURNAL OF HAEMATOLOGY 92 (3) 219 - 228 0902-4441 2014/03 [Refereed]
  
• HTLV-1 bZIP Factor-Specific CD4 T Cell Responses in Adult T Cell Leukemia/Lymphoma Patients after Allogeneic Hematopoietic Stem Cell Transplantation

  Tomoko Narita; Takashi Ishida; Ayako Masaki; Susumu Suzuki; Asahi Ito; Fumiko Mori; Tomiko Yamada; Masaki Ri; Shigeru Kusumoto; Hirokazu Komatsu; Yasuhiko Miyazaki; Yoshifusa Takatsuka; Atae Utsunomiya; Akio Niimi; Shinsuke Iida; Ryuzo Ueda

  JOURNAL OF IMMUNOLOGY 192 (3) 940 - 947 0022-1767 2014/02 [Refereed]
  
• Autologous Tax-Specific CTL Therapy in a Primary Adult T Cell Leukemia/Lymphoma Cell-Bearing NOD/Shi-scid, IL-2R gamma(null) Mouse Model

  Ayako Masaki; Takashi Ishida; Susumu Suzuki; Asahi Ito; Fumiko Mori; Fumihiko Sato; Tomoko Narita; Tomiko Yamada; Masaki Ri; Shigeru Kusumoto; Hirokazu Komatsu; Yuetsu Tanaka; Akio Niimi; Hiroshi Inagaki; Shinsuke Iida; Ryuzo Ueda

  JOURNAL OF IMMUNOLOGY 191 (1) 135 - 144 0022-1767 2013/07 [Refereed]
  
• [Sustained remission with allogeneic peripheral blood stem cell transplantation and subsequent maintenance therapy with dasatinib in a patient with myeloblastic crisis of imatinib-resistant CML].

  Narita T; Kayukawa S; Yoshida T; Kusumoto S; Kataoka T

  [Rinsho ketsueki] The Japanese journal of clinical hematology The Japanese Society of Hematology 54 (3) 279 - 283 0485-1439 2013/03 [Refereed]
  
• Angioimmunoblastic T-cell lymphoma mice model

  Fumihiko Sato; Takashi Ishida; Asahi Ito; Fumiko Mori; Ayako Masaki; Hisashi Takino; Tomoko Narita; Masaki Ri; Shigeru Kusumoto; Susumu Suzuki; Hirokazu Komatsu; Akio Niimi; Ryuzo Ueda; Hiroshi Inagaki; Shinsuke Iida

  LEUKEMIA RESEARCH 37 (1) 21 - 27 0145-2126 2013/01 [Refereed]
  
• Tax is a potential molecular target for immunotherapy of adult T-cell leukemia/lymphoma

  Susumu Suzuki; Ayako Masaki; Takashi Ishida; Asahi Ito; Fumiko Mori; Fumihiko Sato; Tomoko Narita; Masaki Ri; Shigeru Kusumoto; Hirokazu Komatsu; Yasuo Fukumori; Hiroyoshi Nishikawa; Yuetsu Tanaka; Akio Niimi; Hiroshi Inagaki; Shinsuke Iida; Ryuzo Ueda

  CANCER SCIENCE 103 (10) 1764 - 1773 1349-7006 2012/10 [Refereed]
  
• Tax is a potential molecular target for immunotherapy of adult T-cell leukemia/lymphoma

  Susumu Suzuki; Ayako Masaki; Takashi Ishida; Asahi Ito; Fumiko Mori; Fumihiko Sato; Tomoko Narita; Masaki Ri; Shigeru Kusumoto; Hirokazu Komatsu; Yasuo Fukumori; Hiroyoshi Nishikawa; Yuetsu Tanaka; Akio Niimi; Hiroshi Inagaki; Shinsuke Iida; Ryuzo Ueda

  Cancer Science 103 (10) 1764 - 1773 1347-9032 2012/10 [Refereed]
  
• Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing.

  Ri M; Tashiro E; Oikawa D; Shinjo S; Tokuda M; Yokouchi Y; Narita T; Masaki A; Ito A; Ding J; Kusumoto S; Ishida T; Komatsu H; Shiotsu Y; Ueda R; Iwawaki T; Imoto M; Iida S

  Blood Cancer J. 2012 [Refereed]
  

MISC

• The Abnormal Repression of Mir-375 Expression By Overlapping Epigenetic Dysregulations in Myelomas

  Shotaro Tatekawa; Yoshiaki Chinen; Yuji Shimura; Yayoi Matsumura-Kimoto; Hisao Nagoshi; Tsutomu Kobayashi; Eri Kawata; Tomoko Narita; Masaki Ri; Hiroshi Handa; Nobuhiko Uoshima; Shinsuke Iida; Junya Kuroda  BLOOD  128-  (22)  2016/12
• Identification of Circulating Serum microRNAs As Novel Biomarkers Predicting Disease Progression and Sensitivity to Bortezomib Treatment in Multiple Myeloma

  Tomoko Narita; Masaki Ri; Shiori Kinoshita; Takashi Yoshida; Haruhito Totani; Reham Ashour; Ayako Masaki; Asahi Ito; Shigeru Kusumoto; Takashi Ishida; Hirokazu Komatsu; Makoto Osabe; Masahiro Tohkin; Shinsuke Iida  BLOOD  128-  (22)  2016/12
• 多発性骨髄腫に合併したアミロイドーシスの皮膚生検での診断と危険因子における統計学的考察

  的屋 真美; 加藤 裕史; 春本 真以; 村松 伸之介; 西田 絵美; 楠本 茂; 李 政樹; 成田 朋子; 森田 明理  日本皮膚科学会雑誌  126-  (5)  950  -950  2016/05
• 多発性骨髄腫におけるmiR-375のエピジェネティック異常によるPDPK1発現亢進

  立川 章太郎; 知念 良顕; 志村 勇司; 名越 久朗; 古林 勉; 木元 弥生; 河田 英里; 成田 朋子; 李 政樹; 半田 寛; 魚嶋 伸彦; 飯田 真介; 黒田 純也  International Journal of Myeloma  6-  (2)  64  -64  2016/04
• 多発性骨髄腫におけるmiR-375のエピジェネティック異常によるPDPK1発現亢進

  立川 章太郎; 知念 良顕; 志村 勇司; 名越 久朗; 古林 勉; 木元 弥生; 河田 英里; 成田 朋子; 李 政樹; 半田 寛; 魚嶋 伸彦; 飯田 真介; 黒田 純也  International Journal of Myeloma  6-  (2)  76  -76  2016/04
• Chromosomal and genetic analysis to be performed at the treatment of multiple myeloma

  成田 朋子; 李 政樹  血液内科 = Hematology  70-  (5)  581  -584  2015/05
• Chromosomal Translocation (14;16)-Positive Multiple Myeloma Shows Negativity for CD56 Expression and Unfavorable Outcome Even in the Era of Novel Drugs

  Tomoko Narita; Atsushi Inagaki; Tsutomu Kobayashi; Yoshiaki Kuroda; Toshihiro Fukushima; Masahiko Nezu; Shin-ichi Fuchida; Hirotaka Sakai; Naohiro Sekiguchi; Isamu Sugiura; Yoshinobu Maeda; Hiroyuki Takamatsu; Norifumi Tsukamoto; Dai Maruyama; Yasushi Kubota; Minoru Kojima; Kazutaka Sunami; Takaaki Ono; Masaki Ri; Kensei Tobinai; Shinsuke Iida  BLOOD  124-  (21)  2014/12
• MM細胞株を用いた異所性アミラーゼ安定的発現株の樹立とその性状解析

  水野昌平; 花村一朗; 太田明伸; SIVASUNDARAM Karnan; 成田朋子; 李政樹; 後藤峰明; 後藤麻友子; 恒川敬和; 爾見雅人; 飯田真介; 細川好孝; 上田龍三; 仁田正和; 三輪啓志  Int J Myeloma (Web)  4-  (2)  O-1 (WEB ONLY)  2014
• Impact of a phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma

  成田 朋子; 楠本 茂  血液内科  66-  (4)  474  -480  2013/04
• Reduced Expression of HDAC3 Contributes to the Resistance Against HDAC Inhibitor, Vorinostat (SAHA) in Mature Lymphoid Malignancies

  Jianming (Diane) Ding; Masaki Ri; Tomoko Narita; Ayako Masaki; Fumiko Mori; Asahi Ito; Shigeru Kusumoto; Takashi Ishida; Hirokazu Komatsu; Yukimasa Shiotsu; Akio Niimi; Shinsuke Iida  BLOOD  120-  (21)  2012/11

Research Grants & Projects

• 難治性腫瘍のクローン進化におけるTP73スーパーエンハンサーの形成と欠失の意義

  日本学術振興会：科学研究費助成事業

  Date (from‐to) : 2024/04 -2027/03 

  Author : 三田 貴臣; 成田 朋子; 飯田 真介

Other link

researchmap

https://researchmap.jp/naritomo